- TheStreet.com•5 days ago
The promotion of Paul Campanelli to CEO indicates a change in the company's focus from acquiring other firms to its roots as a generic pharmaceutical firm.
- PR Newswire•9 days ago
TORONTO, Sept. 22, 2016 /CNW/ - Trading resumes in: Company: Intellipharmaceutics International Inc. TSX Symbol: I (all issues) Resumption (ET): 4:30 PM IIROC can make a decision to impose a temporary ...
IntelliPharmaCeutics International Inc. (I.TO)
Toronto - Toronto Delayed Price. Currency in CAD
|Day's Range||2.64 - 2.82|
|52wk Range||1.78 - 4.20|
|1y Target Est||N/A|
|P/E Ratio (ttm)||-7.31|
|Avg Vol (3m)||14,112|
|Dividend & Yield||N/A (N/A)|